Tag - MGTA

Developments

Magenta, Dianthus in merger agreement

Magenta Therapeutics (NASDAQ:MGTA) and closely-held Dianthus Therapeutics entered into a definitive merger agreement to combine the companies in an all-stock transaction that is expected to close in the third quarter of...

May 3, 2023

Developments

Magenta Therapeutics reports initial Phase 2 data for stem cell therapy

Magenta Therapeutics (NASDAQ:MGTA) reported preliminary data from its Phase 2 trial testing MGTA-456, a hematopoietic stem cell (HSC) therapy, in patients with inherited metabolic disorders. The Phase 2 study is...

May 10, 2019

Tag - MGTA

Magenta, Dianthus in merger agreement

Magenta Therapeutics reports initial Phase 2 data for stem cell therapy

General

More